V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10330091 | 10056379 | 1.78 | 89.4 | 03 | 2019-09-25 | 2019-10-16 | CABOZANTINIB | 02 | null | CISPLATIN | 100468186 |
| 10330099 | 10056380 | 1.62 | 96.45 | null | 2017-02-09 | 2017-03-05 | CISPLATIN + VINORELBINE | 02 | null | CISPLATIN + GEMCITABINE | 100198106 |
| 10330280 | 10056383 | 1.74 | 54 | Curative (C) | 2017-04-15 | 2017-11-17 | DABRAFENIB | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101748324 |
| 10330398 | 10056384 | 1.66 | null | 03 | null | 2021-09-20 | Cabazitaxel | 02 | null | CABAZITAXEL | 100291968 |
| 10330577 | 10056385 | 1.62 | 84.5 | 03 | 2017-04-02 | 2017-04-03 | CVP R | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100782587 |
| 10330979 | 10056388 | 1.66 | 79 | Palliative (P) | 2016-12-31 | 2020-04-30 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 100452643 |
| 10331112 | 10056389 | 1.85 | 119.5 | Palliative (P) | 2018-04-25 | 2018-07-17 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | CHLORAMBUCIL + OBINUTUZUMAB | 101041789 |
| 10331273 | 10056390 | 1.67 | 62.7 | null | 2013-12-06 | 2019-06-04 | Palbociclib | N | null | PALBOCICLIB | 101694661 |
| 10331403 | 10056391 | 1.77 | 80.2 | Palliative (P) | 2020-11-10 | 2020-11-10 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100152013 |
| 10331998 | 10056395 | 1.75 | 54 | Palliative (P) | 2020-01-17 | 2020-01-17 | Cabazitaxel | 02 | N | CABAZITAXEL | 100211258 |
| 10332007 | 10056396 | 1.7 | 110 | Palliative (P) | 2019-03-16 | 2019-03-27 | DABRAFENIB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100560808 |
| 10332008 | 10056397 | 1.65 | 77.6 | Palliative (P) | 2021-08-04 | 2021-09-01 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101769505 |
| 10332048 | 10056398 | 1.63 | 0 | null | 2020-08-03 | 2020-08-05 | Melphalan IV High dose | 02 | null | MELPHALAN | 100519369 |
| 10332146 | 10056399 | 0 | 60.9 | null | null | 2020-02-16 | null | 02 | null | VINORELBINE | 101600024 |
| 10332197 | 10056400 | 1.66 | 118.5 | null | 2018-04-13 | 2018-04-30 | Cetuximab + FOLFIRI cycle1 | 02 | null | DABRAFENIB | 100121129 |
| 10332234 | 10056401 | 1.71 | 75.9 | 03 | null | 2019-06-13 | Cisplatin + Vinorelbine (IV) | N | N | CABOZANTINIB | 101818860 |
| 10332249 | 10056402 | 1.55 | 75.9 | Palliative (P) | 2018-02-16 | 2019-04-20 | Cyclophosphamide oral | 02 | N | CYCLOPHOSPHAMIDE | 100366434 |
| 10332362 | 10056404 | 1.5 | 94 | Palliative (P) | 2020-12-31 | 2020-12-31 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100373893 |
| 10332384 | 10056405 | 1.69 | 91 | null | 2020-06-24 | 2020-07-22 | VINORELBINE | 02 | null | BORTEZOMIB + THALIDOMIDE | 100402818 |
| 10332419 | 10056406 | 1.65 | 46 | Curative (C) | 2019-05-15 | 2019-11-04 | CABOZANTINIB | 02 | N | NIRAPARIB | 101529331 |
| 10332422 | 10056407 | 1.72 | 0 | null | null | 2018-01-06 | Cabazitaxel | 02 | null | CABAZITAXEL | 101626166 |
| 10332674 | 10056412 | 1.59 | 62 | null | null | 2020-02-16 | DABRAFENIB | 02 | null | FLUOROURACIL | 100583567 |
| 10332677 | 10056413 | 1.69 | 51.3 | null | 2019-07-31 | 2019-08-15 | Cabazitaxel | 02 | null | CABAZITAXEL | 100425584 |
| 10332732 | 10056414 | 1.67 | 71 | Palliative (P) | 2020-06-27 | 2020-07-25 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101500366 |
| 10332984 | 10056415 | 1.8 | 92.1 | Curative (C) | 2016-09-26 | 2016-10-02 | Bortezomib (weekly) | N | N | BORTEZOMIB | 101075859 |
| 10333023 | 10056416 | 1.5 | 51.3 | Curative (C) | 2019-07-12 | 2019-07-25 | Acalabrutinib | 02 | N | FLUOROURACIL | 100192278 |
| 10333027 | 10056417 | 1.85 | 96 | null | null | 2019-08-24 | VINORELBINE | 02 | null | NIRAPARIB | 101560667 |
| 10333337 | 10056420 | 1.65 | 94.2 | Palliative (P) | 2020-04-09 | 2020-04-30 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 100665476 |
| 10333576 | 10056423 | 1.74 | 68.8 | 03 | 2018-03-10 | 2018-03-15 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 101130252 |
| 10333633 | 10056424 | 1.84 | 106.4 | Neo-adjuvant (N) | 2021-06-22 | 2021-07-09 | Palbociclib | 02 | N | PALBOCICLIB | 100614146 |
| 10333691 | 10056426 | 1.67 | 77.8 | 03 | 2019-12-07 | 2020-08-30 | Cabazitaxel | 02 | N | CABAZITAXEL | 101372735 |
| 10333710 | 10056427 | 1.83 | 53.7 | null | null | 2019-08-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100232428 |
| 10333855 | 10056428 | 1.72 | 48 | 03 | 2018-10-27 | 2018-10-27 | Methotrexate intrathecal | 02 | N | METHOTREXATE | 100221537 |
| 10333890 | 10056429 | 1.67 | 110 | Curative (C) | null | 2022-05-11 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100341205 |
| 10334459 | 10056432 | 1.78 | 103 | null | 2020-05-01 | 2020-05-01 | PVD | 02 | null | BORTEZOMIB + PANOBINOSTAT | 100347002 |
| 10334473 | 10056433 | 1.72 | 78.3 | Palliative (P) | null | 2019-11-15 | CISPLATIN + GEMCITABINE | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100854860 |
| 10334484 | 10056434 | 1.54 | 86.1 | Palliative (P) | 2021-02-13 | 2021-02-26 | Doce + Pertuzumab + Trastuz IV Load | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100089947 |
| 10334507 | 10056435 | 1.66 | 0 | Curative (C) | 2019-05-19 | 2019-05-28 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 100200605 |
| 10334541 | 10056436 | 1.68 | 81.6 | null | null | 2017-02-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CAPECITABINE + IRINOTECAN | 100361361 |
| 10334720 | 10056437 | 1.74 | 0 | 03 | 2019-04-11 | 2019-04-12 | Cabazitaxel | 02 | N | CABAZITAXEL | 101330571 |
| 10334840 | 10056438 | 1.59 | 69 | Palliative (P) | 2017-01-12 | 2017-01-21 | Cisplatin | N | N | FLUOROURACIL | 101617369 |
| 10334935 | 10056439 | 1.74 | 101.2 | 03 | 2018-03-01 | 2019-04-13 | Chlorambucil | 02 | null | CHLORAMBUCIL | 101125289 |
| 10335144 | 10056441 | 1.61 | 118 | null | null | 2019-05-13 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | GEMCITABINE | 100996182 |
| 10335315 | 10056442 | 1.69 | 80.2 | null | null | 2021-05-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101458707 |
| 10335355 | 10056443 | 1.88 | 57.8 | Palliative (P) | 2019-06-13 | 2019-07-08 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100130889 |
| 10335394 | 10056445 | 1.59 | 99.3 | null | 2021-04-26 | 2021-05-07 | Azacitidine | 02 | null | AZACITIDINE | 101699397 |
| 10335562 | 10056446 | null | null | Palliative (P) | 2018-04-26 | 2018-04-26 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | CHLORAMBUCIL + OBINUTUZUMAB | 101091484 |
| 10335701 | 10056447 | 1.7 | 83.7 | null | 2017-11-03 | 2017-11-03 | Melphalan IV High dose | 02 | null | MELPHALAN | 100714838 |
| 10335705 | 10056448 | 1.74 | 71.9 | null | 2016-09-09 | 2016-10-04 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 100507697 |
| 10335799 | 10056449 | null | 52 | null | null | 2019-06-17 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | CABOZANTINIB | 100110642 |